Prevalence of tumour-infiltrating CD103 + cells identifies therapeutic-sensitive prostate cancer with poor clinical outcome.
Quan ZhouYuxi OuXiyu DaiXinan ChenSiqi WuWensun ChenMeng-Bo HuChen YangLimin ZhangHaowen JiangPublished in: British journal of cancer (2023)
T cells exhibited a powerful anti-tumour immunity with response to HT.